Capula Management’s Pediatrix Medical MD Stock Holding History

Capula Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,272	Closed	-$250K	–	773
2025 Q1	$250K	Buy	+17,272	New	+$245K	﹤0.01%	455

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capula Management's MD Position: Q2 2025 in Review

Capula Management sold out of Pediatrix Medical (MD) in Q2 2025, closing a stake of 17,272 shares — an estimated $250K sold.

Capula Management first reported a position in MD in Q1 2025 and held it in 1 quarter. The position peaked at $250K in Q1 2025. 264 funds tracked by Wall St. Rank hold MD as of Q2 2025.

Capula Management reported no remaining Pediatrix Medical position as of Q2 2025 after selling out during the quarter.
Capula Management sold 17,272 Pediatrix Medical shares in Q2 2025, an estimated $250K.
Capula Management first reported a position in Pediatrix Medical in Q1 2025 and held it in 1 quarter.
Capula Management's Pediatrix Medical position peaked at $250K in Q1 2025.
264 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2025.

Based on Capula Management's 13F filing for Q2 2025, filed 13 Aug 2025.